Sign Up
OverviewAPI
Abeona Therapeutics grants equity awards to three new non-executive employees, totaling 25,500 restricted shares, with a vesting period of three years. This move aligns with Nasdaq regulations and showcases the company's commitment to retaining top talent in the biopharmaceutical industry.

Ask a question